Skip to content

Lupus Intervention for Fatigue Trial

Lupus Intervention for Fatigue Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02653287
Acronym
LIFT
Enrollment
200
Registered
2016-01-12
Start date
2019-05-01
Completion date
2027-12-31
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue, Lupus Erythematosus, Systemic, Physical Activity

Keywords

Fatigue, Physical Activity, Lupus

Brief summary

Participants in the Chicago Lupus Database or individuals seen at Northwestern Medicine will be approached to enroll in a one year clinical trial looking at decreasing fatigue in persons with systemic lupus erythematosus (SLE). The intervention group will receive individual coaching sessions focusing on physical activity and nutrition while the control group will receive individual calls in relation to SLE self-management educational sessions.This study is designed to evaluate the LIFT intervention to decrease fatigue (primary outcome), improve physical activity (secondary outcome) and dietary behavior (exploratory outcome) in persons with SLE.

Detailed description

Participants in the Chicago Lupus Database or individuals seen at Northwestern Medicine will be approached to enroll in a one year clinical trial looking at decreasing fatigue in persons with systemic lupus erythematosus (SLE). The intervention group will receive individual coaching based in motivational interviewing sessions focusing on physical activity and nutrition while the control group will receive individual calls focusing on SLE self-management. This study is designed to evaluate the LIFT intervention to decreased fatigue (primary outcome), improve physical activity (secondary outcome) and dietary behavior (exploratory outcome) in persons with SLE.

Interventions

BEHAVIORALExperimental

The experimental intervention includes 4 individual coaching sessions (initial 1 hour in-person and remaining 10-15 minutes per telephone) designed to identify barriers and supports for physical activity and nutrition using motivational interviewing. They occur shortly after randomization, 1.5, 3, and 6 months. Daily participants monitor their physical activity via the Fitbit Flex and their dietary behavior on a paper diary.

OTHERControl

The control group will receive four individual phone calls focusing on education for SLE disease management, as well as answering any questions the participants have about the study. Topics include: what is lupus, laboratory tests, medications, taking charge of your health care and managing stress (2 sessions). Each call will last about 10-15 minutes, and occur shortly after randomization, then at 1.5, 3, and 6 months.

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* include meeting at least 4 of 11 American College of Rheumatology (ACR) classification criteria for definite SLE, or 3 out of 11 ACR classification criteria with also meeting at least one SLICC criteria * be at least 18 years of age * have a BMI between 18-40 kg/m2 * be able to ambulate at least household distances (50ft) * be able to provide informed consent. * be able to speak and read English

Exclusion criteria

* include pregnancy at baseline * not meeting inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Change in Fatigue Severity Scale over timeBaseline, 3, 6, 12 monthsOnline questionnaire

Secondary

MeasureTime frameDescription
Change in Physical Activity Scale over timeBaseline, 3, 6, 12 monthsAccelerometry
Change in International Physical Activity Questionnaire (IPAQ) over timeBaseline, 3, 6, 12 monthsPhone Interview Questionnaire
Godin Leisure Time Exercise QuestionnaireBaseline, 6, 12 monthsPhone Interview Questionnaire

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRosalind Ramsey-Goldman, MD, DrPH

Northwestern University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026